GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nextage Therapeutics Ltd (XTAE:NXTG) » Definitions » Pretax Margin %

Nextage Therapeutics (XTAE:NXTG) Pretax Margin % : -249.79% (As of Dec. 2023)


View and export this data going back to 1993. Start your Free Trial

What is Nextage Therapeutics Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Nextage Therapeutics's Pre-Tax Income for the six months ended in Dec. 2023 was ₪-1.78 Mil. Nextage Therapeutics's Revenue for the six months ended in Dec. 2023 was ₪0.71 Mil. Therefore, Nextage Therapeutics's pretax margin for the quarter that ended in Dec. 2023 was -249.79%.

The historical rank and industry rank for Nextage Therapeutics's Pretax Margin % or its related term are showing as below:

XTAE:NXTG' s Pretax Margin % Range Over the Past 10 Years
Min: -31282.14   Med: -4905.01   Max: -479.79
Current: -479.8


XTAE:NXTG's Pretax Margin % is ranked worse than
92.46% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 4.12 vs XTAE:NXTG: -479.80

Nextage Therapeutics Pretax Margin % Historical Data

The historical data trend for Nextage Therapeutics's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nextage Therapeutics Pretax Margin % Chart

Nextage Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial -653.30 -8,359.16 -8,717.58 - -479.79

Nextage Therapeutics Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,187.76 - - -1,485.89 -249.79

Competitive Comparison of Nextage Therapeutics's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Nextage Therapeutics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nextage Therapeutics's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nextage Therapeutics's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Nextage Therapeutics's Pretax Margin % falls into.



Nextage Therapeutics Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Nextage Therapeutics's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-4.203/0.876
=-479.79 %

Nextage Therapeutics's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-1.781/0.713
=-249.79 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nextage Therapeutics  (XTAE:NXTG) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Nextage Therapeutics Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Nextage Therapeutics's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nextage Therapeutics (XTAE:NXTG) Business Description

Traded in Other Exchanges
N/A
Address
Bio-Light, Kiryat Atidim 7, Entrance 1, 2rd Floor, Tel Aviv, ISR, 61581
Nextage Therapeutics Ltd is a holding company. The company, through its subsidiaries, is engaged in the development of biological marker, a molecule/gene, which when present in the body at abnormal levels indicates development of a disease. It is focused on the development and commercialization of cancer diagnostic products.

Nextage Therapeutics (XTAE:NXTG) Headlines